facebook twitter instagram linkedin google youtube vimeo tumblr yelp rss email podcast phone blog search brokercheck brokercheck Play Pause

Biograph Wealth Advisors

Blog


The Hidden Risks of Share-Based Compensation - Part IV Thumbnail

The Hidden Risks of Share-Based Compensation - Part IV

In our previous article on SBC, we looked at the gap between the returns people should get from putting their money to work and the lower returns they tend to get instead. Often that is because they are not experts in financial planning and investing, or they simply do not have the time.

Read More
The Hidden Risk of Share Based Compensation - Part III Thumbnail

The Hidden Risk of Share Based Compensation - Part III

A typical saver who parks their cash in a safe, protected savings account still faces the risk of inflation eating away at the value of their money. By the time they come to spend it, their money may have increased slightly on paper, but lost value in real terms.

Read More
The Hidden Risk of Share Based Compensation - Part II Thumbnail

The Hidden Risk of Share Based Compensation - Part II

You bought a racehorse and the biggest meeting of the year is coming up. Having already invested time and money into this horse, regardless of the odds and the conditions and the competition, you feel almost obliged to back it on the day as well.

Read More
Beyond the Index : Improving on a Great Idea Thumbnail

Beyond the Index : Improving on a Great Idea

In 1900, America had around 4,000 millionaire families. If those families had done nothing clever at all, simply invested in the stock market, spent a modest slice each year and left the rest to compound, the maths says they should have produced somewhere in the region of 16,000 billionaire households by today.

Read More
If You Knew the Headlines in Advance, Would You Have Picked the Winner ? Thumbnail

If You Knew the Headlines in Advance, Would You Have Picked the Winner ?

A thought experiment on why even perfect foresight about the news is not enough, and why owning the market usually is. Imagine it is the end of 1999. The millennium is about to turn, the dot-com boom is at full roar, and someone hands you tomorrow's newspapers for the next 25 years. Not the share prices, just the headlines. You flick through and two pharmaceutical stories jump out.

Read More